Cliff Asness's LRMR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 817,517 shares of Larimar Therapeutics, Inc. (LRMR) worth $3.68 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 8 quarters.
Based on 13F filings, Cliff Asness has maintained this position in LRMR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 316,262 shares. Largest reduction occurred in Q4 2025, reducing 60,152 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Larimar Therapeutics (LRMR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Larimar Therapeutics (LRMR) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +315,266 | Add 62.77% | 817,517 | $4.50 |
| Q4 2025 | -60,152 | Reduce 10.70% | 502,251 | $3.81 |
| Q3 2025 | +133,915 | Add 31.25% | 562,403 | $3.23 |
| Q2 2025 | +316,262 | Add 281.81% | 428,488 | $2.89 |
| Q1 2025 | +112,226 | New Buy | 112,226 | $2.15 |
| Q4 2024 | -15,712 | Sold Out | 0 | $0.00 |
| Q3 2024 | +86 | Add 0.55% | 15,712 | $6.55 |
| Q2 2024 | +15,626 | New Buy | 15,626 | $7.25 |
Cliff Asness's Larimar Therapeutics Investment FAQs
Cliff Asness first purchased Larimar Therapeutics, Inc. (LRMR) in Q2 2024, acquiring 15,626 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Larimar Therapeutics, Inc. (LRMR) for 8 quarters since Q2 2024.
Cliff Asness's largest addition to Larimar Therapeutics, Inc. (LRMR) was in Q2 2025, adding 428,488 shares worth $1.24 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 817,517 shares of Larimar Therapeutics, Inc. (LRMR), valued at approximately $3.68 M.
As of the Q1 2026 filing, Larimar Therapeutics, Inc. (LRMR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Larimar Therapeutics, Inc. (LRMR) was 817,517 shares, as reported at the end of Q1 2026.